FDA Warns of Fracture Risk in Zimmer Biomet Hip Implants
Oliver
September 27, 2024
WASHINGTON, DC – The U.S. Food and Drug Administration issued an urgent safety communication Wednesday regarding Zimmer Biomet’s CPT Hip System, citing an increased risk of thigh bone fractures in patients with the implant. The FDA’s warning comes after Zimmer Biomet initiated a voluntary recall on July 2 to update